<DOC>
	<DOC>NCT03002545</DOC>
	<brief_summary>This study aims to determine how a 12-week magnesium supplementation with 400 mg magnesium from organic magnesium citrate affects blood glucose control and insulin resistance within patients with type 2 diabetes (HbA1c&gt; 6%) and how the expression of certain Mg-sensitive transporting genes is affected .</brief_summary>
	<brief_title>Magnesium Supplementation in Type II Diabetes</brief_title>
	<detailed_description>The examinations are carried out in 50 subjects aged 20-80 years with existing type 2 diabetes (HbA1c&gt; 6%). The target parameters are determined in the blood. Blood sampling takes place at confinement, after 6 weeks and at the end of the study (week 12). In addition, blood pressure is determined and general health condition of each subject is recorded by a standardized questionnaire (SF-36).</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Magnesium citrate</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<criteria>Type II Diabetics (HbA1c &gt; 6%) pregnancy, lactation persons with severe renal impairment (glomerular filtration rate &lt;30 ml / min) use of insulin, oral antidiabetic drugs, diuretics, antacids or proton pump inhibitors within 4 weeks prior to study start and during the study intake of vitamin supplements, dietary supplements, mineral products or possibly enriched foods containing Magnesium within 4 weeks before study start and during the study</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Magnesium</keyword>
	<keyword>Type II diabetes</keyword>
	<keyword>magnesium-sensitive genes</keyword>
</DOC>